Mr. Louis Dron reports

REDWOOD AI ANNOUNCES PLATFORM NAME CHANGE AND APPOINTMENT OF DR. MARK DYBUL AS PUBLIC SAFETY & DEFENSE ADVISOR

Redwood AI Corp. will effect a name change to its proprietary artificial-intelligence-powered chemical synthesis platform. The platform, formerly known as SythesAltzer, has been renamed Reactosphere, a name chosen to reflect the platform's evolution beyond synthesis route generation into a more advanced intelligence system capable of supporting applications across multiple industries.

Originally developed to apply artificial intelligence and machine learning to complex chemical synthesis and reaction modelling, the platform has evolved into a broader architecture designed to support advanced chemistry applications across multiple industries, including life sciences, health care, public safety, biosecurity and strategic defence-related technologies. The platform integrates chemical intelligence, data-driven modelling and scalable computational tools designed to assist organizations in addressing complex scientific and operational challenges.

As Redwood works to expand the strategic applications of its platform across areas, including public safety, biosecurity and defence-related technologies, the company is also pleased to announce the appointment of Dr. Mark R. Dybul as public safety and defence adviser to the company.

Dr. Dybul is a physician, scientist and internationally recognized public health leader with more than two decades of experience in infectious disease research, global health policy and large-scale health care program implementation. He served as U.S. global AIDS co-ordinator under President George W. Bush, where he led the implementation of the president's emergency plan for AIDS relief, one of the largest international health initiatives in history.

Dr. Dybul held the rank of Rear Admiral in the U.S. Public Health Service and served as assistant U.S. surgeon general, reflecting his leadership in national and global public health initiatives. He later served as executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, one of the world's largest international health financing organizations dedicated to combatting infectious diseases. Dr. Dybul is currently a professor of medicine at Georgetown University, and has spent more than 25 years working as a clinician, researcher and global health leader addressing infectious diseases, health system development and international health policy.

In his role as public safety and defence adviser, Dr. Dybul will provide strategic guidance to the company with respect to the potential use cases for the platform to address challenges relating to global health systems, public health preparedness, biosecurity, global health security and the intersection of advanced scientific technologies with public safety and broader national security considerations.

"Artificial intelligence has the potential to play an increasingly important role in addressing complex global challenges across health care, biosecurity and public safety. I look forward to supporting Redwood as it continues to develop technologies that can contribute to innovation across these critical areas," stated Dr. Dybul.

About Redwood AI Corp.

Redwood AI uses advanced artificial intelligence to accelerate chemistry research and development, with the aim of assisting in drug discovery and development, and furthering defence and safety solutions. The company combines expertise in chemistry, AI and manufacturing to streamline drug synthesis and scale-up. Redwood AI's platform enables faster, more efficient development of new therapies and chemistry-driven applications.

We seek Safe Harbor.